Home › Research › Caregiving
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels GJ, Despa F.. Nature reviews. Endocrinology, 2018-10-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Cognitive dysfunction is increasingly recognized as an important comorbidity of diabetes mellitus. Different stages of diabetes-associated cognitive dysfunction exist, each with different cognitive features, affected age groups and prognoses and probably with different underlying mechanisms. Relatively subtle, slowly progressive cognitive decrements occur in all age groups. More severe stages, particularly mild cognitive impairment and dementia, with progressive deficits, occur primarily in older individuals (>65 years of age). Patients in the latter group are the most relevant for patient management and are the focus of this Review. Here, we review the evolving insights from studies on risk factors, brain imaging and neuropathology, which provide important clues on mechanisms of both the subtle cognitive decrements and the more severe stages of cognitive dysfunction. In the majority of patients, the cognitive phenotype is probably defined by multiple aetiologies. Although both the risk of clinically diagnosed Alzheimer disease and that of vascular dementia is increased in association with diabetes, the cerebral burden of the prototypical pathologies of Alzheimer disease (such as neurofibrillary tangles and neuritic plaques) is not. A major challenge for researchers is to pinpoint from the spectrum of diabetes-related disease processes those that affect the brain and contribute to development of dementia beyond the pathologies of Alzheimer disease. Observations from experimental models can help to meet that challenge, but this requires further improving the synergy between experimental and clinical scientists. The development of targeted treatment and preventive strategies will therefore depend on these translational efforts.
What this study adds
Evidence grade: Low
This is a narrative review. This 2018 review separates mild, slowly progressing thinking changes, which it says occur with diabetes at all ages, from mild cognitive impairment and dementia, which occur "primarily in older individuals (>65 years of age)" and are its focus. It tests no treatment, and says targeted treatment and prevention will depend on further research linking laboratory and clinical work.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Biessels, G. J., & Despa, F. (2018). Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature reviews. Endocrinology. https://doi.org/10.1038/s41574-018-0048-7
Vancouver
Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature reviews. Endocrinology. 2018. doi:10.1038/s41574-018-0048-7. PMID: 30022099.
BibTeX
@article{biessels2018-30022099,
author = {Biessels, G. J. and Despa, F.},
title = {{Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications}},
journal = {Nature reviews. Endocrinology},
year = {2018},
doi = {10.1038/s41574-018-0048-7},
pmid = {30022099},
url = {https://doi.org/10.1038/s41574-018-0048-7}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- In the majority of patients, the cognitive phenotype is probably defined by multiple aetiologies.
- Although both the risk of clinically diagnosed Alzheimer disease and that of vascular dementia is increased in association with diabetes, the cerebral burden of the prototypical pathologies of Alzheimer disease (such as neurofibrillary tangles and neuritic plaques) is not.
- A major challenge for researchers is to pinpoint from the spectrum of diabetes-related disease processes those that affect the brain and contribute to development of dementia beyond the pathologies of Alzheimer disease.
- Observations from experimental models can help to meet that challenge, but this requires further improving the synergy between experimental and clinical scientists.
- The development of targeted treatment and preventive strategies will therefore depend on these translational efforts.
Why it matters
This 2018 review separates mild, slowly progressing thinking changes, which it says occur with diabetes at all ages, from mild cognitive impairment and dementia, which occur "primarily in older individuals (>65 years of age)" and are its focus. It reports that the risk of clinically diagnosed Alzheimer's and of vascular dementia is increased in association with diabetes, while the brain's burden of Alzheimer's hallmark tangles and plaques is not, and it concludes that in most patients the cognitive problems probably have "multiple aetiologies". It tests no treatment, and says targeted treatment and prevention will depend on further research linking laboratory and clinical work.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Evidence strengthLow
How this study scored 53/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Nature reviews. Endocrinology) |
| Journal's citation record | 3 / 4 | Nature Reviews Endocrinology: journal h-index 265 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,439 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 143.9 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | 4 / 6 | Cited 13.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 45 other studies in this library |
| Still being cited | 4 / 4 | Cited 739 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Florin Despa: h-index 26 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University Medical Center Utrecht: institution h-index 1,076 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30022099) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 42.
Later studies that cite this one
45 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Caregiving from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.